You have 9 free searches left this month | for more free features.

Overall Status

Completed (19)

Active, not recruiting (2)

Terminated (2)

Unknown status (2)

Withdrawn (1)

Sign in for free

Phase

phase 1 (17)

phase 2 (5)

phase 1/phase 2 (3)

n/a (1)

Collaborator

Novartis Pharmaceuticals (5)

Novartis (3)

Brown University (1)

Chungnam National University Hospital (1)

Korean Cancer Study Group (1)

Lifespan (1)

NantCell, Inc. (1)

Novartis Pharmaceuticals Corporation (Financial supporter) (1)

Study Documents

Intervention Type

drug (26)

radiation (3)

Funder Type

Industry (13)

Other (13)

Study Type

Interventional (26)

byl719

Showing 26 - 26 of 26

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced and Selected Solid Tumors, AML, High Risk and Very High Risk MDS Trial in Worldwide (BYL719, MEK162)

Completed

Advanced and Selected Solid Tumors
+2 more

BYL719
MEK162

La Jolla, California
+15 more

Sep 29, 2017